Importantly, in tumors with high ALDH1 activity, we observed increased expression of ZEB1 and decreased expression of NGN3 (Figure 6C and 6D), strongly suggesting that dysregulated ZEB1/NGN3 signaling is functionally linked to tumor stem cell traits in breast cancer. This evidence concerns the gene ALDH1A1 and breast cancer.